Travere Therapeutics CAO Sandra Calvin to retire; John Torell to succeed

Travere Therapeutics, Inc.

Sandra Calvin to retire as CAO/PAO after filing 10-K expected in February 2027.
John Torell, current VP Controller, to be appointed CAO/PAO before retirement date.
Torell joined Travere in 2021; previously VP Controller at Pacific Life and audit manager at Deloitte.
Torell holds CFA and CPA designations; transition plan aims for orderly handover.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.